| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.27B | 38.03B | 37.58B | 35.48B | 32.77B | 16.81B |
| Gross Profit | 5.21B | 3.63B | 4.83B | 7.43B | 4.62B | -3.00M |
| EBITDA | 4.00B | 3.07B | 4.66B | 5.33B | 3.73B | 96.00M |
| Net Income | 1.55B | 1.29B | 1.38B | 1.67B | 791.00M | -2.19B |
Balance Sheet | ||||||
| Total Assets | 50.75B | 49.40B | 47.05B | 45.32B | 43.34B | 42.54B |
| Cash, Cash Equivalents and Short-Term Investments | 7.71B | 8.14B | 8.49B | 8.27B | 8.30B | 7.60B |
| Total Debt | 13.03B | 14.55B | 14.23B | 13.95B | 15.17B | 16.69B |
| Total Liabilities | 38.34B | 37.69B | 35.46B | 35.61B | 34.86B | 38.05B |
| Stockholders Equity | 12.34B | 11.64B | 11.54B | 9.66B | 8.40B | 4.45B |
Cash Flow | ||||||
| Free Cash Flow | -264.51M | -707.91M | -6.00M | 895.00M | 2.66B | -700.00M |
| Operating Cash Flow | 4.55B | 3.59B | 3.89B | 4.95B | 5.17B | 618.00M |
| Investing Cash Flow | -2.36B | -3.37B | -2.33B | -2.98B | -3.44B | -3.02B |
| Financing Cash Flow | -2.86B | -816.45M | -1.45B | -2.07B | -2.27B | 2.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $27.88B | 269.96 | 27.85% | 1.37% | 16.68% | 51.06% | |
72 Outperform | $46.46B | -37.50 | 23.14% | 0.96% | 5.24% | 20.93% | |
71 Outperform | $31.11B | 10.76 | 24.91% | ― | 4.73% | 1.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $11.97B | -3.27 | 12.23% | 3.41% | 13.11% | 30.65% | |
57 Neutral | $19.30B | 20.61 | 10.67% | 1.73% | 4.72% | 72.71% | |
50 Neutral | $8.39B | -4.65 | -5.17% | ― | 3.33% | -70.60% |